RecallDepth
Class I Terminated

8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02

Company
Pfizer Inc.
Recall Initiated
March 15, 2019
Posted
April 10, 2019
Recall Number
D-1073-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
283,400 vials
Firm Location
New York, NY, United States

Reason for Recall

Presence of Particulate Matter; glass particulates

Distribution

United States and Puerto Rico

Lot / Code Info

Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class I Drug recalls